St. Jude Medical (St. Paul, Minnesota) said it has received FDA approval to begin the EnligHTN IV renal denervation study, the first U.S. trial using the EnligHTN multi-electrode renal denervation system to treat patients with drug-resistant high blood pressure. Read More
